BMY vs TSE · P/E 17, rev $24.46B vs rev $3.51B
Bristol-Myers Squibb Company (BMY) versus Trinseo SA (TSE) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Christopher S. Boerner Ph.D..
Trinseo SA (TSE) is a specialty chemicals company listed on NYSE.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported TSE revenue for 2024-12-31 was $3.51B. Net income was -$348.5M. Revenue was down 4.4% from 2023-12-31 to 2024-12-31. TSE currently screens at market cap $8.3M.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. TSE currently screens at market cap $8.3M.
Not investment advice. Open the BMY and TSE stock pages for the full models.
Not investment advice.